{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390010457669443840.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.5551/jat.58941"}},{"identifier":{"@type":"PMID","@value":"33907060"}},{"identifier":{"@type":"URI","@value":"https://www.jstage.jst.go.jp/article/jat/29/5/29_58941/_pdf"}},{"identifier":{"@type":"NAID","@value":"130008030727"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2023169719"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p><b>Aim:</b> To assess the results of a phase I/IIa open-label dose-escalation clinical trial of 5-day repeated intramuscular administration of pitavastatin-incorporated poly (lactic-co-glycolic acid) nanoparticles (NK-104-NP) in patients with chronic limb threatening ischemia (CLTI).</p><p><b>Methods:</b> NK-104-NP was formulated using an emulsion solvent diffusion method. NK-104-NP at four doses (nanoparticles containing 0.5, 1, 2, and 4 mg of pitavastatin calcium, n=4 patients per dose) was investigated in a dose-escalation manner and administered intramuscularly into the ischemic limbs of 16 patients with CLTI. The safety and therapeutic efficacy of treatment were investigated over a 26-week follow-up period.</p><p><b>Results:</b> No cardiovascular or other serious adverse events caused by NK-104-NP were detected during the follow-up period. Improvements in Fontaine and Rutherford classifications were noted in five patients (one, three, and one in the 1-, 2-, and 4-mg dose groups, respectively). Pharmacokinetic parameters including the maximum serum concentration and the area under the blood concentration–time curve increased with pitavastatin treatment in a dose-dependent manner. The area under the curve was slightly increased at day 5 compared with that at day 1 of treatment, although the difference was not statistically significant.</p><p><b>Conclusions:</b> This is the first clinical trial of pitavastatin-incorporated nanoparticles in patients with CLTI. Intramuscular administration of NK-104-NP to the ischemic limbs of patients with CLTI was safe and well tolerated and resulted in improvements in limb function.</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410010457669443841","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187131"}],"foaf:name":[{"@language":"en","@value":"Matsumoto Takuya"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Vascular Surgery, National Hospital Organization Fukuoka-higashi Medical Center"},{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443846","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187133"}],"foaf:name":[{"@language":"en","@value":"Yoshino Shinichiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751146229376","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00419590"},{"@type":"NRID","@value":"1000000419590"},{"@type":"NRID","@value":"9000001467014"},{"@type":"NRID","@value":"9000002948688"},{"@type":"NRID","@value":"9000305641401"},{"@type":"NRID","@value":"9000243901121"},{"@type":"NRID","@value":"9000412187134"},{"@type":"NRID","@value":"9000272996083"},{"@type":"NRID","@value":"9000411953622"},{"@type":"NRID","@value":"9000405873557"},{"@type":"NRID","@value":"9000257988377"},{"@type":"NRID","@value":"9000005784617"},{"@type":"NRID","@value":"9000283614371"},{"@type":"NRID","@value":"9000257988799"},{"@type":"NRID","@value":"9000243877907"},{"@type":"NRID","@value":"9000415194127"},{"@type":"NRID","@value":"9000415088513"},{"@type":"NRID","@value":"9000408578562"},{"@type":"NRID","@value":"9000257996831"},{"@type":"NRID","@value":"9000002138811"},{"@type":"NRID","@value":"9000326265929"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/stentgraft"}],"foaf:name":[{"@language":"en","@value":"Furuyama Tadashi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443848","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187135"}],"foaf:name":[{"@language":"en","@value":"Morisaki Koichi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443844","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187136"}],"foaf:name":[{"@language":"en","@value":"Nakano Kaku"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801183277568","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10746142"},{"@type":"NRID","@value":"1000010746142"},{"@type":"NRID","@value":"9000398259897"},{"@type":"NRID","@value":"9000326651942"},{"@type":"NRID","@value":"9000413780993"},{"@type":"NRID","@value":"9000412187137"},{"@type":"NRID","@value":"9000398996325"},{"@type":"NRID","@value":"9000362230941"},{"@type":"NRID","@value":"9000312724865"},{"@type":"NRID","@value":"9000414835414"},{"@type":"NRID","@value":"9000004236855"},{"@type":"NRID","@value":"9000408578561"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/j-koga"}],"foaf:name":[{"@language":"en","@value":"Koga Jun-ichiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University"},{"@language":"en","@value":"Department of Cardiovascular Medicine, Kyusyu University Graduate School of Medical Sciences"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443843","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187138"}],"foaf:name":[{"@language":"en","@value":"Maehara Yoshihiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443849","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187139"}],"foaf:name":[{"@language":"en","@value":"Komori Kimihiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443842","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187140"}],"foaf:name":[{"@language":"en","@value":"Mori Masaki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410010457669443845","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000412187132"}],"foaf:name":[{"@language":"en","@value":"Egashira Kensuke"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University"},{"@language":"en","@value":"Department of Translational Medicine, Kyushu University Graduate School of Pharmaceutical Sciences"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13403478"},{"@type":"EISSN","@value":"18803873"}],"prism:publicationName":[{"@language":"en","@value":"Journal of Atherosclerosis and Thrombosis"},{"@language":"ja","@value":"Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ"},{"@language":"en","@value":"JAT"},{"@language":"en","@value":"J Atheroscler Thromb"},{"@language":"ja","@value":"Ｊ　Ａｔｈｅｒｏｓｃｌｅｒ　Ｔｈｒｏｍｂ"}],"dc:publisher":[{"@language":"en","@value":"Japan Atherosclerosis Society"},{"@language":"ja","@value":"一般社団法人 日本動脈硬化学会"}],"prism:publicationDate":"2022-05-01","prism:volume":"29","prism:number":"5","prism:startingPage":"731","prism:endingPage":"746"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://www.jstage.jst.go.jp/article/jat/29/5/29_58941/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2023169719"}],"availableAt":"2022-05-01","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Drug%20delivery%20system","dc:title":"Drug delivery system"},{"@id":"https://cir.nii.ac.jp/all?q=Angiogenesis","dc:title":"Angiogenesis"},{"@id":"https://cir.nii.ac.jp/all?q=Arteriogenesis","dc:title":"Arteriogenesis"},{"@id":"https://cir.nii.ac.jp/all?q=Peripheral%20arterial%20disease","dc:title":"Peripheral arterial disease"},{"@id":"https://cir.nii.ac.jp/all?q=Statin","dc:title":"Statin"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004236435919104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004237573529856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004237596664704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145594065664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals."}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145633966720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711411443840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292617916130816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619561907200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620680436096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096340415616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096578420352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570557920128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518853410432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Amelioration of Ischemic Mitochondrial Injury and Bax‐Dependent Outer Membrane Permeabilization by Mdivi‐1"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520467414528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521295964800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994998669824","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A novel nucleic acid analogue shows strong angiogenic activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469712898432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945540331136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945949071616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946305607424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pitavastatin"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419507788544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844728493696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318935266304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Rapid endo‐lysosomal escape of poly(DL‐lactide‐\n                    <i>co</i>\n                    glycolide) nanoparticles: implications for drug and gene delivery"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320720933760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapeutic Neovascularization by Nanotechnology-Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268694662528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204431765504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288073262080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Safety, Tolerability, and Pharmacokinetics of NK-104-NP"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288095800960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390002184886344832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679407445248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pitavastatin-Incorporated Nanoparticle-Eluting Stents Attenuate In-Stent Stenosis without Delayed Endothelial Healing Effects in a Porcine Coronary Artery Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680201702272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390579134185725568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Vascular Involvement in Patients with Lower Extremity Artery Disease: Difference of Distribution Pattern among Smoking, Diabetes Mellitus, and End-Stage Renal Disease"},{"@value":"Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2009318140"},{"@type":"CROSSREF","@value":"10.5551/jat.58941"},{"@type":"PUBMED","@value":"33907060"},{"@type":"CIA","@value":"130008030727"},{"@type":"OPENAIRE","@value":"doi_dedup___::a5d575817762219ebdaa53345450d252"},{"@type":"CROSSREF","@value":"10.5551/jat.64007_references_DOI_NDJlYrA9xFtxvvIb97TuYo2KsBV"}]}